WatermarkBBrandtLIkelerHBodenR. Pregabalin is increasingly prescribed for neuropathic pain, generalized anxiety disorder and epilepsy but many patients discontinue treatment. Int J Clin Pract. 2014;68:104-110.
2.
OlaizolaIEllgerTYoungPBosebackFEversSKellinghausC. Pregabalin-associated acute psychosis and epileptiform EEG-changes. Seizure. 2006;15:208-221.
3.
HuppertzHJFeuersteinTJSchulze-BonhageA. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia. 2001;42:790-792.
4.
BragaAJChidleyK. Self-poisoning with lamotrigine and pregabalin. Anaesthesia. 2001;62:524-527.
5.
SpillerHABratcherRGriffithsJRK. Pregabalin overdose with benign outcome. Clin Toxicol (Phila). 2008;46:917.
6.
YooLMatalonDHoffmanRSGoldfarbDS. Treatment of pregabalin toxicity by haemodialysis in a patient with kidney failure. Am J Kidney Dis. 2009;54:1127-1130.
RandinitisEJPosvarELAlveyCWSedmanAJCookJABockbraderHN. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol. 2003;43:277-283.
9.
Al-HusseiniAWazaifyMVan HoutMC. Pregabalin misuse and abuse in Jordan: a qualitative study of user experiences. Int J Ment Health Addict. 2018;16:642-654.
10.
SchwanSSundströmAStjernbergEHallbergEHallbergP. A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Pharmacol. 2010;66:947-953.
11.
IsoardiKZPolkinghorneGHarrisKIsbisterGK. Pregabalin poisoning and rising recreational use: a retrospective observational series. Br J Clin Pharmacol. 2020;86:2435-2440.
